What are the Jones criteria for diagnosing rheumatic fever and what is the recommended management, including antibiotic therapy, anti‑inflammatory treatment, and secondary prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rheumatic Fever: Diagnostic Criteria and Management

Diagnosis: Revised Jones Criteria (2015)

The diagnosis of acute rheumatic fever requires evidence of preceding group A streptococcal infection PLUS either 2 major manifestations OR 1 major plus 2 minor manifestations, with different thresholds for low-risk versus moderate/high-risk populations 1.

Risk Population Stratification

  • Low-risk populations: ARF incidence ≤2 per 100,000 school-aged children or RHD prevalence ≤1 per 1000 population
  • Moderate/high-risk populations: Higher incidence rates (includes most developing countries)

Major Criteria

Low-Risk Populations:

  • Carditis (clinical and/or subclinical on echocardiography)
  • Polyarthritis only
  • Chorea
  • Erythema marginatum
  • Subcutaneous nodules

Moderate/High-Risk Populations:

  • Carditis (clinical and/or subclinical)
  • Monoarthritis OR polyarthritis
  • Polyarthralgia (after excluding other causes)
  • Chorea
  • Erythema marginatum
  • Subcutaneous nodules

Minor Criteria

Low-Risk Populations:

  • Polyarthralgia
  • Fever ≥38.5°C
  • ESR ≥60 mm/h and/or CRP ≥3.0 mg/dL
  • Prolonged PR interval (unless carditis is major criterion)

Moderate/High-Risk Populations:

  • Monoarthralgia
  • Fever ≥38°C
  • ESR ≥30 mm/h and/or CRP ≥3.0 mg/dL
  • Prolonged PR interval (unless carditis is major criterion)

Critical Diagnostic Points

The 2015 revision represents a major shift by incorporating subclinical carditis detected by echocardiography as a major criterion 1. This requires strict adherence to specific echocardiographic criteria for pathological mitral or aortic regurgitation, accounting for circulatory loading conditions and blood pressure at time of examination 1.

For recurrent ARF: Diagnosis requires 2 major OR 1 major and 2 minor OR 3 minor manifestations with evidence of preceding streptococcal infection 1.


Management

Acute Phase Treatment

1. Streptococcal Eradication (First Priority)

Administer benzathine penicillin G as a single intramuscular dose for streptococcal eradication, or use oral penicillin V or azithromycin as alternatives 2.

2. Anti-Inflammatory Therapy

Salicylates (aspirin) are the initial treatment of choice for arthritis in acute rheumatic fever 3. However, recent evidence suggests ibuprofen may be a safer alternative, particularly in children under 11 years of age 4.

The comparative study found:

  • No difference in clinical efficacy between aspirin and ibuprofen (hospital stay, symptom resolution, acute-phase reactant normalization)
  • Significantly fewer hepatotoxic effects with ibuprofen: liver enzyme elevation occurred in 62% of aspirin-treated patients versus only 18% with ibuprofen (P=0.009) 4
  • 69% of aspirin-related liver toxicity occurred in children under 11 years 4

Treatment duration: 12 weeks total for anti-inflammatory therapy 2. Corticosteroids may be added for severe carditis, though specific indications should be based on clinical severity 2.

3. Management of Cardiac Complications

Treat congestive heart failure, valvular disease, and atrial fibrillation according to standard cardiac protocols 2. Chorea requires treatment according to severity, continuing for 2-3 weeks after clinical improvement 2.


Secondary Prophylaxis (Critical for Preventing RHD)

Benzathine benzylpenicillin G intramuscular injections every 4 weeks is the recommended regimen for secondary prophylaxis 5, 6.

Evidence Supporting Secondary Prophylaxis

Intramuscular benzathine benzylpenicillin is approximately 10 times more effective than oral antibiotics in preventing rheumatic fever recurrence (0.1% vs 1% recurrence rate; RR 0.07,95% CI 0.02-0.26) 6.

Antibiotics overall reduce rheumatic fever recurrence substantially compared to no treatment (0.7% vs 1.7%; RR 0.39,95% CI 0.22-0.69) 6. Patients with early or mild RHD have the greatest capacity to benefit, with recurrence rates of 0.7% with prophylaxis versus 8.1% without (RR 0.09,95% CI 0.03-0.29) 6.

Alternative Regimens

  • For non-severe or immediate penicillin hypersensitivity: Use erythromycin orally twice daily 5
  • For dental/surgical procedures: Patients on benzathine penicillin prophylaxis still require amoxicillin prophylaxis before high-risk procedures; use clindamycin if recent penicillin/amoxicillin exposure or immediate hypersensitivity 5

Duration of Prophylaxis

Continue secondary prophylaxis based on:

  • Presence and severity of cardiac involvement
  • Time since last ARF episode
  • Risk of streptococcal exposure
  • Individual patient factors

For patients not fully meeting diagnostic criteria ("possible" rheumatic fever), consider 12 months of secondary prophylaxis followed by reevaluation including repeat echocardiogram 1.


Important Caveats

Diagnostic Pitfalls

  • Distinguish subclinical carditis from physiological valve regurgitation: Use continuous-wave Doppler; signals that are not holosystolic with peak velocity <3.0 m/s are more likely physiological 1
  • Exclude alternative diagnoses before accepting monoarthritis or polyarthralgia as major criteria in moderate/high-risk populations 1, 7
  • Joint manifestations can only count as EITHER major OR minor criteria, not both 1
  • Account for blood pressure and circulatory loading conditions during echocardiographic assessment 1

Treatment Considerations

  • Monitor liver enzymes during aspirin therapy, especially in children under 11 years 4
  • Hypersensitivity reactions and local injection site reactions are more common with antibiotics compared to no treatment, though serious adverse events (anaphylaxis, sciatic nerve injury) remain rare 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.